Articles tagged "Progressive supranuclear palsy(PSP)"

2019 International Congress
Aberrant structural connectivity of the executive network in Progressive Supranuclear Palsy
S. Prasad, A. Rajan, S. Mangalore, J. Saini, M. Ingalhalikar, P. Pal (Bangalore, India)
Objective: To ascertain the structural connectivity of the executive network in progressive supranuclear palsy (PSP) using probabilistic tractography. Background: Cognitive deficits are highly prevalent in…
2019 International Congress
White matter abnormalities correlate with clinical features in PSP patients
A. Campabadal, A. Abos, B. Segura, HC. Baggio, C. Uribe, A. Garrido, A. Camara, E. Muñoz, F. Valldeoriola, MJ. Martí, C. Junqué, Y. Compta (Barcelona, Spain)
Objective: To detect white matter abnormalities in PSP patients and their correlation with motor and cognitive impairment. Background: Progressive Supranuclear Palsy (PSP) is a tauopathy…
2019 International Congress
Clinical Correlates of Genetic and Biomarker Profiles in Patients with Progressive Supranuclear Palsy: Data from the ARISE Study
H. Soares, Z. Jin, N. Fisseha, M. Gold, C. Locke, B. Rendenbach-Mueller, E. Smith, I. Suridjan, A. Vasanthakumar, N. Mendonca (Ludwigshafen, Germany)
Objective: To characterize the genetic and biomarker profile of patients with Progressive Supranuclear Palsy (PSP) and the relationship of potential biomarkers with baseline disease severity.…
2019 International Congress
Baseline analysis of PROSPECT-M-UK: a longitudinal study of PSP, CBS and MSA
E. Jabbari, J. Woodside, V. Chelban, A. Costantini, N. Holland, N. Leigh, D. Burn, N. Pavese, A. Gerhard, C. Kobylecki, M. Hu, A. Church, J. Rohrer, H. Houlden, J. Rowe, H. Morris (London, United Kingdom)
Objective: To complete the baseline analysis of clinical data from the PROSPECT-M-UK study and to assess the impact of applying current MDS PSP diagnostic criteria…
2019 International Congress
Validation of the Movement Disorder Society criteria for the diagnosis of 4R-tauopathies
G. Respondek, MJ. Grimm, I. Piot, T. Arzberger, Y. Compta, E. Englund, LW. Ferguson, E. Gelpi, A. Giese, S. Roeber, DJ. Irwin, WG. Meissner, C. Nilsson, A. Pantelyat, A. Rajput, JB. Rowe, JC. van Swieten, C. Troakes, GU. Höglinger (London, United Kingdom)
Objective: To validate the accuracy of the newly proposed Movement Disorder Society diagnostic criteria for progressive supranuclear palsy (MDS-PSP criteria, Höglinger et al., 2017) to…
2019 International Congress
Molecular correlates of survival and clinical severity in Progressive Supranuclear Palsy
M. Malpetti, L. Passamonti, T. Rittman, P. Vázquez Rodríguez, W R. Bevan-Jones, F I. Aigbirhio, J T. O'Brien, J B. Rowe (Cambridge, United Kingdom)
Objective: To test how regional tau pathology and neuroinflammation are associated with clinical severity and survival in progressive supranuclear palsy (PSP). Background: The abnormal aggregation…
2019 International Congress
Validation of the diagnostic criteria for progressive supranuclear palsy in pathologically confirmed patients
I. Aiba, Y. Saito, Y. Yokokawa, T. Katayama, M. Kenjo, R. Hashimoto, S. Sakakibara, M. Sato, H. Nakatsuji, A. Inukai, Y. Iwasaki, M. Mimuro, A. Akagi, M. Yoshida (Nagoya, Japan)
Objective: To assess the sensitivity and specificity of the diagnostic criteria for progressive supranuclear palsy (PSP). Background: The International Parkinson and Movement Disorder Society criteria…
2019 International Congress
Concomitant brain pathologies have no major impact on clinical milestones in progressive supranuclear palsy
M. Jecmenica-Lukic, C. Kurz, G. Respondek, O. Grau-Rivera, Y. Compta, E. Gelpi, C. Troakes, J. van Swieten, A. Giese, S. Roeber, T. Arzberger, G. Höglinger (Munich, Germany)
Objective: To analyze the frequency and severity of co-pathologies in PSP patients and their relevance for the clinical presentation and progression in PSP. Background: The phenotypic…
2019 International Congress
Abnormal metabolic brain network in multiple system atrophy and progressive supranuclear palsy: a replication on a new European cohort
T. Rus, E. Rebec, P. Tomše, A. Studen, M. Grmek, C. Tang, D. Eidelberg, M. Trošt (Ljubljana, Slovenia)
Objective: To identify characteristic metabolic brain patterns specific for multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) in a new cohort of patients and…
2019 International Congress
Is 18F-FDG-PET/CT a helpful tool to diagnose PSP clinical variants?
G. Marti-Andres, M. Riverol-Fernandez, R. Valentí-Azcárate, M. Fernández-Matarrubia, E. Prieto-Azcárate, J. Arbizu-Azcarate, MR. Luquin-Piudo (Pamplona, Spain)
Objective: To assess if there are differential metabolic brain patterns among Progressive Supranuclear Palsy(PSP) clinical variants and between them and Parkinson’s disease patients (PD). Background:…